UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 9.893

Sortiert nach

The activation mechanism of ACK1 (activated Cdc42-associated tyrosine kinase 1)

Biochemical journal, 2012-07, Vol.445 (2), p.255-264

2012

Volltextzugriff (PDF)

Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation

European Journal of Cancer, 2009-08, Vol.45 (12), p.2197-2206

2009

Volltextzugriff (PDF)

Celastrol acts synergistically with afatinib to suppress non‐small cell lung cancer cell proliferation by inducing paraptosis

Journal of cellular physiology, 2021-06, Vol.236 (6), p.4538-4554

2021

Volltextzugriff (PDF)

Multi-targeted approach in the treatment of thyroid cancer

Therapeutics and clinical risk management, 2008-10, Vol.4 (5), p.935-947

2008

Volltextzugriff (PDF)

Synthesis and Evaluation of 2-Amine-4-oxyphosaniline Pyrimidine Derivatives as EGFR L858R/T790M/C797S Mutant Inhibitors

Chemical and Pharmaceutical Bulletin, 2023/02/01, Vol.71(2), pp.140-147

2023

Volltextzugriff (PDF)

CDK4/6 inhibitor palbociclib overcomes acquired resistance to third‐generation EGFR inhibitor osimertinib in non‐small cell lung cancer (NSCLC)

Thoracic cancer, 2020-09, Vol.11 (9), p.2389-2397

2020

Volltextzugriff (PDF)

The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study

Frontiers in immunology, 2022-09, Vol.13, p.975246-975246

2022

Volltextzugriff (PDF)

The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan

Thoracic cancer, 2022-05, Vol.13 (10), p.1505-1512

2022

Volltextzugriff (PDF)

Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells

Journal of thoracic disease, 2023-04, Vol.15 (4), p.1978-1993

2023

Volltextzugriff (PDF)

Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives

Translational lung cancer research, 2023-04, Vol.12 (4), p.824-836

2023

Volltextzugriff (PDF)

Concurrent chemotherapy and first‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first‐line treatment in advanced lung adenocarcinoma harboring an EGFR mutation

Thoracic cancer, 2021-08, Vol.12 (16), p.2233-2240

2021

Volltextzugriff (PDF)

Real‐world utilization of EGFR TKIs and prognostic factors for survival in EGFR‐mutated non‐small cell lung cancer patients with brain metastases

International journal of cancer, 2021-09, Vol.149 (5), p.1121-1128

2021

Volltextzugriff (PDF)

Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review

Translational lung cancer research, 2021-09, Vol.10 (9), p.3823-3839

2021

Volltextzugriff (PDF)

Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges

Critical reviews in oncology/hematology, 2012-07, Vol.83 (1), p.130-144

Langer, Corey J

2012

Volltextzugriff (PDF)

EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles

International journal of pharmaceutics, 2021-01, Vol.592, p.120082-120082, Article 120082

2021

Volltextzugriff (PDF)

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered

The FEBS journal, 2013-11, Vol.280 (21), p.5350-5370

2013

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer

Oncotarget, 2017-07, Vol.8 (30), p.50209-50220

2017

Volltextzugriff (PDF)

Comparing the effectiveness of different EGFR‐TKIs in patients with EGFR mutant non–small‐cell lung cancer: A retrospective cohort study in Taiwan

International journal of cancer, 2020-08, Vol.147 (4), p.1107-1116

2020

Volltextzugriff (PDF)

A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study)

Translational lung cancer research, 2023-08, Vol.12 (8), p.1802-1806

2023

Volltextzugriff (PDF)

Targeting HER1/EGFR in cancer therapy: experience with erlotinib

Future oncology (London, England), 2005-08, Vol.1 (4), p.449-460

Giaccone, Giuseppe

2005

Volltextzugriff (PDF)

A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy

Bioorganic chemistry, 2020-06, Vol.99, p.103811-103811, Article 103811

2020

Volltextzugriff (PDF)

Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib

Oncology, 2011-04, Vol.79 (5-6), p.423-429

2011

Volltextzugriff (PDF)

Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo

Oncology research, 2013, Vol.20 (7), p.303

2013

Volltextzugriff (PDF)

EGF receptor trafficking: consequences for signaling and cancer

Trends in cell biology, 2014-01, Vol.24 (1), p.26-34

2014

Volltextzugriff (PDF)

1 – 25 von 9.893

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8.962)
Mit Volltextzugriff
(9.342)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(9.039)
Life Sciences & Biomedicine
(8.846)
Humans
(7.027)
Egfr
(5.353)
Oncology
(4.505)
Female
(3.078)
Epidermal Growth Factor Receptors
(3.041)
Mutation
(2.797)
Epidermal Growth Factor
(2.622)
Receptor, Epidermal Growth Factor - Metabolism
(2.483)
Male
(2.423)
Receptor, Epidermal Growth Factor - Genetics
(2.274)
Tumors
(2.239)
Animals
(2.143)
Lung Cancer
(2.125)
Middle Aged
(1.988)
Cell Line, Tumor
(1.955)
Aged
(1.853)
Epidermal Growth Factor Receptor
(1.853)
Kinases
(1.804)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(7.664)
EZB Electronic Journals Library
(5.487)
Ingenta
(5.054)
Journals@Ovid Full Text
(3.112)
IngentaConnect Journals
(2.930)
Elsevier ScienceDirect Journals Complete
(1.937)
Springer Nature
(1.740)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.652)
Wiley Journals
(1.444)
Single Journals
(1.120)
Wiley Online Library Full Collection 2018
(1.044)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.028)
Access via Taylor & Francis
(568)
Taylor & Francis Current Content Access
(442)
Nexis Uni
(421)
Taylor & Francis Journals Complete
(347)
Nature_系列刊
(342)
SAGE Journals
(200)
Oxford Journals
(161)
SpringerLink Series
(146)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(275)
Cancers
(242)
International Journal Of Molecular Sciences
(200)
Anticancer Research
(198)
Oncotarget
(196)
Journal Of Thoracic Oncology
(163)
Bmc Cancer
(160)
The Journal Of Biological Chemistry
(148)
Journal Of Biological Chemistry/the journal Of Biological Chemistry
(144)
Oncogene
(143)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt